RECRUITINGOBSERVATIONAL
Retrospective Cohort Study of Low-Flow Extracorporeal Carbon Dioxide Removal (ECCO2R) System: Evaluating ECCO2R's Efficacy and Safety in Participants With Respiratory Failure
Retrospective Cohort Study of Low-Flow Extracorporeal Carbon Dioxide Removal (ECCO2R) System: Evaluating Efficacy and Safety
About This Trial
This is an observational study performed by retrospective review of data routinely collected for patients receiving low-flow extracorporeal carbon dioxide removal (ECCO2R) therapy in intensive care units (ICUs). Our aim is to firstly, describe the local practice in terms of patient selection and technical details of clinical management related to the use of low-flow ECCO2R system, and secondly, the clinical results in terms of patient outcomes and adverse events. These findings may allow clinicians to improve the quality and safety of ECCO2R therapy provision in the ICU.
Who May Be Eligible (Plain English)
Who May Qualify:
- Patients supported with ECCO2R in one of the designated study sites
- Admitted to the ICU between 1 Jan 2022 and 30 June 2024
Who Should NOT Join This Trial:
- Patients younger than 18 years old
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Patients supported with ECCO2R in one of the designated study sites
* Admitted to the ICU between 1 Jan 2022 and 30 June 2024
Exclusion Criteria:
* Patients younger than 18 years old
Locations (1)
Queen Mary Hospital (QMH)
Hong Kong, Hong Kong